Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

Correll, Christoph U., Detraux, Johan, De Lepeleire, Jan, De Hert, Marc·2015·World Psychiatry

Cites (286)

Items 201–286 of 286

  1. Psychiatric and General Medical Conditions Comorbid With Bipolar Disorder in the National Hospital Discharge Survey
    Natalya S. Weber, Jared A. Fisher, David N. Cowan, David W. Niebuhr · 2011 · Psychiatric Services
  2. Body Mass Index, Obesity, and Psychopathology in Patients With Schizophrenia
    M. Subramaniam, Max Lam, Meng-En Guo, V. He, Jimmy Lee, S. Verma, S. Chong · 2014 · Journal of Clinical Psychopharmacology
  3. Incidence of Tardive Dyskinesia with Risperidone or Olanzapine in the Elderly: Results from a 2-Year, Prospective Study in Antipsychotic-Naïve Patients
    Margaret G. Woerner, Christoph Ulrich Correll, Jose Ma. J. Alvir · 2011 · Neuropsychopharmacology
  4. Use of Antidepressant Medications and Risk of Fracture in Older Women
    Susan J. Diem, TERRI L. BLACKWELL, Katie L. Stone, Jane A. Cauley, Teresa A. Hillier, Elizabeth M Haney, Kristine E. Ensrud · 2011 · Calcified Tissue International
  5. Second-Generation Antipsychotic Use in Schizophrenia and Associated Weight Gain: A Critical Review and Meta-Analysis of Behavioral and Pharmacologic Treatments
    Chandan Das, Guillermo Mendez, Sonal Jagasia, Lawrence A. Labbate · 2012 · Annals of Clinical Psychiatry
  6. Postmortem analysis of cardiovascular deaths in schizophrenia: A 10-year review
    Sweeting, Joanna, Duflou, Johan, Semsarian, Christopher · 2013 · Schizophrenia Research
  7. Evidence for the Partial Dopamine-Receptor Agonist Aripiprazole as a First-Line Treatment of Psychosis in Patients With Iatrogenic or Tumorogenic Hyperprolactinemia
    Zachary S. Hoffer, Richard L. Roth, Maju Mathews · 2009 · Psychosomatics
  8. Excess mortality of acute and transient psychotic disorders: comparison with bipolar affective disorder and schizophrenia
    Augusto C. Castagnini, Leslie Foldager, Aksel Bertelsen · 2013 · Acta Psychiatrica Scandinavica
  9. Antidepressants: Influence on cancer and immunity?
    Luciana Romina Frick, Maximiliano Rapanelli · 2013 · Life Sciences
  10. Brugada Syndrome ECG Is Highly Prevalent in Schizophrenia
    Marieke T. Blom, Dan Cohen, Adrie Seldenrijk, Brenda W.J.H. Penninx, Giel Nijpels, Coen D.A. Stehouwer, Jacqueline M. Dekker, Hanno L. Tan · 2014 · Circulation Arrhythmia and Electrophysiology
  11. The incidence of cardiovascular morbidity among patients with bipolar disorder: A population-based longitudinal study in Ontario, Canada
    Russell C. Callaghan, Anbreen Khizar · 2009 · Journal of Affective Disorders
  12. Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose
    Peter Vestergaard, Daniel Prieto‐Alhambra, M K Javaid, Cyrus C. Cooper · 2012 · Osteoporosis International
  13. Review: Meta-analysis of the effects of lithium usage on serum creatinine levels
    R. Paul, J. Minay, Chris R. Cardwell, Damian G. Fogarty, C. Kelly · 2009 · Journal of Psychopharmacology
  14. An Integrated Bioinformatics Approach Identifies Elevated Cyclin E2 Expression and E2F Activity as Distinct Features of Tamoxifen Resistant Breast Tumors
    Lei Huang, Shuangping Zhao, Jonna M. Frasor, Yang David Dai · 2011 · PLoS ONE
  15. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
    Jegan Yogaratnam, N Biswas, R Vadivel, R Jacob · 2013 · PubMed
  16. Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study
    Ruth Brauer, Liam L Smeeth, Karim Anaya‐Izquierdo, Adam Timmis, Spiros Denaxas, Paddy Farrington, Heather Whitaker, Harry Hemingway, Ian Douglas · 2014 · European Heart Journal
  17. Depression and bone mass
    Itai Bab, Raz Yirmiya · 2010 · Annals of the New York Academy of Sciences
  18. The association between antipsychotic agents and the risk of myocardial infarction: a systematic review
    Ruth Brauer, Ian Douglas, Liam L Smeeth · 2011 · British Journal of Clinical Pharmacology
  19. Quantifying the Role of Adverse Events in the Mortality Difference between First and Second-Generation Antipsychotics in Older Adults: Systematic Review and Meta-Synthesis
    John W. Jackson, Sebastian Schneeweiß, Tyler J. VanderWeele, Deborah Blacker · 2014 · PLoS ONE
  20. Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
    Haishan Wu, Lu Deng, Lipin Zhao, Jingping Zhao, Lehua Li, Jindong Chen · 2013 · International Journal of Endocrinology
  21. Inverse association between cancer risks and age in schizophrenic patients: A 12‐year nationwide cohort study
    Chun‐Yuan Lin, Hsien‐Yuan Lane, Tsi‐Ting Chen, Yu‐Hsin Wu, Chun‐Ying Wu, Vivian Yaling Wu · 2013 · Cancer Science
  22. Second-Generation Antipsychotic–Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need
    Dan Cohen, Christoph Ulrich Correll · 2009 · The Journal of Clinical Psychiatry
  23. Antipsychotic Treatment in Breast Cancer Patients
    Tahir Rahman, Charles V. Clevenger, Virginia Kaklamani, John Lauriello, Austin R. Campbell, Kari Malwitz, Robert S. Kirkland · 2014 · American Journal of Psychiatry
  24. Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome
    Olivier Bruyère, Jean‐Yves Reginster · 2014 · Endocrine
  25. Effects of Switching From Olanzapine, Quetiapine, and Risperidone to Aripiprazole on 10-Year Coronary Heart Disease Risk and Metabolic Syndrome Status: Results From a Randomized Controlled Trial
    Stroup, T. Scott, Byerly, Matthew J., Nasrallah, Henry A., Ray, Neepa, Khan, Ahsan Y., Lamberti, J. Steven, Glick, Ira D., Steinbook, Richard M., McEvoy, Joseph P., Hamer, Robert M. · 2013 · Schizophrenia Research
  26. Incidence of Cardiovascular Outcomes and Diabetes Mellitus Among Users of Second-Generation Antipsychotics
    Leslie Citrome, Jenna M. Collins, Beth L. Nordstrom, Edward J. Rosen, Ross A. Baker, Anagha Nadkarni, Iftekhar D. Kalsekar · 2013 · The Journal of Clinical Psychiatry
  27. Risk of Fractures with Selective Serotonin-Reuptake Inhibitors or Tricyclic Antidepressants
    Regina Ginzburg, Enma Rosero · 2008 · Annals of Pharmacotherapy
  28. The risks of major osteoporotic fractures in patients with schizophrenia: A population-based 10-year follow-up study
    Kuan‐Yi Tsai, Ching‐Chih Lee, Yu-Mei Chou, Shih‐Pei Shen, Chao‐Yueh Su, Hung‐Chi Wu, Min‐Wei Huang, Jia-Pei Shie, Frank Huang‐Chih Chou · 2014 · Schizophrenia Research
  29. Psychotropic drugs and the risk of fractures in old age: a prospective population-based study
    Janne Nurminen, Juha Puustinen, Maarit Piirtola, Tero J. Vahlberg, Sirkka‐Liisa Kivelä · 2010 · BMC Public Health
  30. Prevalence of diabetes in patients with major depressive disorder: a population-based study
    I‐Chia Chien, En‐Liang Wu, Ching-Heng Lin, Yiing‐Jenq Chou, Pesus Chou · 2011 · Comprehensive Psychiatry
  31. Risk of Falls and Fractures in Older Adults Using Antipsychotic Agents
    Sandhya Mehta, Hua Chen, Michael L. Johnson, Rajender R. Aparasu · 2010 · Drugs & Aging
  32. An ode to the joy of Beethoven's 9th.
    Randy A. Sansone, Lori A Sansone · 2012 · Europe PMC (PubMed Central)
  33. Mortality associated with depression as compared with other severe mental disorders: a 20-year follow-up study of the GAZEL cohort.
    C. Lemogne, H. Nabi, M. Melchior, M. Goldberg, F. Limosin, S. Consoli, M. Zins · 2013 · Journal of Psychiatric Research
  34. Risk of Falls and Fractures in Older Adults Using Atypical Antipsychotic Agents: A Propensity Score–Adjusted, Retrospective Cohort Study
    Satabdi Chatterjee, Hua Chen, Michael L. Johnson, Rajender R. Aparasu · 2012 · The American Journal of Geriatric Pharmacotherapy
  35. Use of antidepressants and the risk of breast cancer: a meta-analysis
    Chun-Sick Eom, Sang Min Park, Kyung-Hwan Cho · 2012 · Breast Cancer Research and Treatment
  36. Antipsychotics and Associated Risk of Out-of-Hospital Cardiac Arrest
    Peter Ejvin Weeke, Aksel Karl Georg Jensen, Fredrik Folke, Gunnar Gislason, Jonas Bjerring Olesen, Emil Loldrup Fosbøl, Mads Wissenberg, Freddy Knudsen Lippert, Erika Frischknecht Christensen, Søren Loumann Nielsen et al. · 2014 · Clinical Pharmacology & Therapeutics
  37. Mapping the prescriptiome to fractures in men—a national analysis of prescription history and fracture risk
    Bo Abrahamsen, Kim Brixen · 2008 · Osteoporosis International
  38. Motor Symptoms of Schizophrenia: Is Tardive Dyskinesia a Symptom or Side Effect? A Modern Treatment
    Vladimir Lerner, Chanoch Miodownik · 2011 · Current Psychiatry Reports
  39. Novel Loci Associated with Increased Risk of Sudden Cardiac Death in the Context of Coronary Artery Disease
    Adriana Huertas‐Vázquez, Christopher P. Nelson, Xiuqing Guo, Kyndaron Reinier, Audrey Uy‐Evanado, Carmen Teodorescu, Jo Ayala, Katherine Jerger, Harpriya S. Chugh, WTCCC WTCCC et al. · 2013 · PLoS ONE
  40. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
    Janet E. Ashbury, Linda E. Lévesque, Patricia A. Beck, Kristan J. Aronson · 2012 · Frontiers in Oncology
  41. Increased Risks of Acute Organ Dysfunction and Mortality in Intensive Care Unit Patients With Schizophrenia
    Hsiu-Nien Shen, Chin‐Li Lu, Hsi-Hsing Yang · 2011 · Psychosomatic Medicine
  42. A 52-Week, Double-Blind Evaluation of the Metabolic Effects of Aripiprazole and Lithium in Bipolar I Disorder
    Roger S. McIntyre, Susan L. McElroy, James M. Eudicone, Robert A. Forbes, Berit X. Carlson, Ross A. Baker · 2011 · The Primary Care Companion For CNS Disorders
  43. Selective serotonin reuptake inhibitors and torsade de pointes : new concepts and new directions derived from a systematic review of case reports
    Christopher Kogut, Ericka L. Breden Crouse, W. Victor R. Vieweg, Mehrul Hasnain, Adrian M Baranchuk, Geneviève C. Digby, Jayanthi N. Koneru, Antony Fernandez, Anand R. Deshmukh, Jules C. Hancox et al. · 2013 · Therapeutic Advances in Drug Safety
  44. The use of atypical antipsychotics and the risk of breast cancer
    Laurent Azoulay, Hui Yin, Christel Renoux, Samy Suissa · 2011 · Breast Cancer Research and Treatment
  45. Psychotropic drugs and renal failure: Translating the evidence for clinical practice
    Nour T. baghdady, Suman Banik, Shari A. Swartz · 2009 · Advances in Therapy
  46. Relations of Depressive Symptoms and Antidepressant Use to Body Mass Index and Selected Biomarkers for Diabetes and Cardiovascular Disease
    Yunsheng Ma, Raji Balasubramanian, Sherry Pagoto, Kristin L. Schneider, James R. Hébert, Lawrence S. Phillips, Joseph S. Goveas, Annie L. Culver, Barbara C. Olendzki, Jürgen Beck et al. · 2013 · American Journal of Public Health
  47. Opioids, antiepileptic and anticholinergic drugs and the risk of fractures in patients 65 years of age and older: a prospective population-based study
    Janne Nurminen, Juha Puustinen, Maarit Piirtola, Tero J. Vahlberg, A. Lyles, Sirkka‐Liisa Kivelä · 2012 · Age and Ageing
  48. Use of SSRIs May Impact Bone Density in Adolescent and Young Women With Anorexia Nervosa
    Madhusmita Misra, M. Le Clair, Nara Mendes, Karen Klahr Miller, Elizabeth Austen Lawson, Erinne M. Meenaghan, Thomas J. Weigel, Seda Ebrahimi, David B. Herzog, Anne Klibanski · 2010 · CNS Spectrums
  49. Which psychotropic medications induce hepatotoxicity?
    Karim Sedky, Racha Nazir, Aditya Joshi, Gagandeep Kaur, Steven Lippmann · 2011 · General Hospital Psychiatry
  50. Anticholinergic Effects of Oral Antipsychotic Drugs of Typicals Versus Atypicals Over Medium- and Long-Term: Systematic Review and Meta-Analysis
    Mehmet Ozbilen, C.E. Adams, J. Marley · 2012 · Current Medicinal Chemistry
  51. The “depressive” face of osteoporosis and the “osteoporotic” face of depression
    Kyriakos Aloumanis, Kostantinos Mavroudis · 2013 · HORMONES
  52. Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern?
    Kristina Star, Andrew Bate, Ronald H.B. Meyboom · 2010 · British Journal of General Practice
  53. Antidepressant drugs as a complementary therapeutic strategy in cancer
    Anna Bielecka, Ewa Obuchowicz · 2013 · Experimental Biology and Medicine
  54. Second-generation antipsychotics and bone turnover in schizophrenia
    Kyoji Okita, Nobuhisa Kanahara, Motoi Nishimura, Toshihiko Yoshida, Norio Yasui‐Furukori, Tomihisa Niitsu, Taisuke Yoshida, Masatomo Ishikawa, Hiroshi Kimura, Fumio Nomura et al. · 2014 · Schizophrenia Research
  55. Lithium and Kidney, 60 Years Later
    Michele Raja · 2011 · Current Drug Safety
  56. Use of Antipsychotics and Risk of Cerebrovascular Events in Schizophrenic Patients
    Pei-Hua Hsieh, Fei‐Yuan Hsiao, Susan Shur‐Fen Gau, Churn‐Shiouh Gau · 2013 · Journal of Clinical Psychopharmacology
  57. Metabolic issues in psychotic disorders with the focus on first-episode patients: a review.
    Dubravka Britvić, Nadja P. Marić, Mirjana Doknić, Sandra Pekić, Sanja Andric, Miroslava Jašović‐Gašić, Vera M. POPOVIC · 2013 · PubMed
  58. Association of Antidepressant and Atypical Antipsychotic Use with Cardiovascular Events and Mortality in a Veteran Population
    Tushar Acharya, Sabeena Acharya, Steven Tringali, Jian Huang · 2013 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  59. Metabolic changes in first‐episode early‐onset schizophrenia with second‐generation antipsychotics
    Brian N. O'Donoghue, Miriam R. Schäfer, Jana Becker, Konstantinos Papageorgiou, G. Paul Amminger · 2013 · Early Intervention in Psychiatry
  60. Fracture risks of antidepressants
    Peter Vestergaard · 2008 · Expert Review of Neurotherapeutics
  61. Venlafaxine-induced Cholestatic Hepatitis
    Sylvia Stadlmann, Susanne Portmann, Stefan Tschopp · 2012 · The American Journal of Surgical Pathology
  62. Prevalence of Overweight and Obesity in Adolescents With Severe Mental Illness
    Barbara Gracious, Stephen R. Cook, Ashley E. Meyer · 2010 · The Journal of Clinical Psychiatry
  63. Commentary on a recent review of lithium toxicity: what are its implications for clinical practice?
    Bruno Müller-Oerlinghausen, Michael Bauer, Paul Grof · 2012 · BMC Medicine
  64. Antidepressant use, depression, lifestyle factors, and new-onset diabetes
    Tricia Lee Wilkins, Usha Sambamoorthi · 2011 · International Clinical Psychopharmacology
  65. Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data
    Jeffrey R. Curtis, Huifeng Yun, Jeff L. Lange, Robert Matthews, Pradeep Sharma, Kenneth G. Saag, Elizabeth Delzell · 2012 · Arthritis Care & Research
  66. Thyroid function and lipid profile in bipolar I patients
    Asma Ezzaher, Dhouha Haj Mouhamed, Anouar Mechri, Fadoua Neffati, Wahiba Douki, Lotfi Gaha, Mohamed Fadhel Najjar · 2011 · Asian Journal of Psychiatry
  67. Diabetes Risk Potentially Underestimated in Youth and Children Receiving Antipsychotics
    Katherine Samaras, Christoph Ulrich Correll, Alex J. Mitchell, Marc D. Binder · 2014 · JAMA Psychiatry
  68. Atypical Antipsychotics Olanzapine, Quetiapine, and Risperidone and Risk of Acute Major Cardiovascular Events in Young and Middle-Aged Adults: A Nationwide Register-Based Cohort Study in Denmark
    Björn Pasternak, Henrik Svanström, Mattis Flyvholm Ranthe, Mads Melbye, Anders Peter Hviid · 2014 · CNS Drugs
  69. Exploring the Potential Effect of Polypharmacy on the Hematologic Profiles of Clozapine Patients
    Michael D. Shuman, Eileen Trigoboff, Tammie Lee Demler, Lewis A. Opler · 2014 · Journal of Psychiatric Practice
  70. Antipsychotic exposure prior to acute myocardial infarction in patients with serious mental illness
    Shu‐I Wu, Kai‐Liang Kao, Shyr‐Chyr Chen, Jyh‐Ming Jimmy Juang, Chien‐Jung Lin, Chun‐Kai Fang, Chi‐Shin Wu, Michael E. Dewey, Martin James Prince, Robert J. Stewart · 2014 · Acta Psychiatrica Scandinavica
  71. Do SSRIs Play a Role in Decreasing Bone Mineral Density?
    Fonda Chen, Theodore J. Hahn, Nancy T. Weintraub · 2011 · Journal of the American Medical Directors Association
  72. Calcaneal Bone Mineral Density in Young Adults Prescribed Selective Serotonin Reuptake Inhibitors
    Charles F. Seifert, Tara R. Wiltrout · 2013 · Clinical Therapeutics
  73. Effects of Long-Term Combination Treatment with Valproate and Atypical Antipsychotics on Bone Mineral Density and Bone Metabolism in Premenopausal Patients with Bipolar Disorder: A Preliminary Study
    Jae-Won Yang, Sook-Haeng Joe, Moon‐Soo Lee · 2011 · Psychiatry Investigation
  74. Adherence to Treatment with Selective Serotonin Reuptake Inhibitors and the Risk for Fractures and Bone Loss
    Inbar Zucker, Gabriel Chodick, Leon J. Grunhaus, Raanan Raz, Varda Shalev · 2012 · CNS Drugs
  75. Risk of nonvertebral fractures among elderly postmenopausal women using antidepressants
    Véronique Rabenda, Olivier Bruyère, Jean‐Yves Reginster · 2012 · Bone
  76. Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia
    For the Depakote psychosis group, Daniel E. Casey, David Gordon Daniel, Adel A. Wassef, Latherine A Tracy, Patricia Wozniak, Kenneth William Sommerville · 2003 · Neuropsychopharmacology
  77. Cancer comortality patterns in schizophrenia and psychotic disorders: a new methodological approach for unique databases
    Vladeta Ajdacic‐Gross, Alois Tschopp, Matthias Bopp, Félix Gutzwiller, Wulf Rössler A · 2014 · International Journal of Methods in Psychiatric Research
  78. Do psychiatric medications, especially antidepressants, adversely impact maternal metabolic outcomes?
    Maite López-Yarto, Eider Ruiz-Mirazo, Alison C. Holloway, Valerie H. Taylor, Sarah Diana McDonald · 2012 · Journal of Affective Disorders
  79. Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram
    Chi‐Un Pae, Sheng‐Min Wang, Soo-Jung Lee, Changsu Han, Ashiwn A Patkar, Prakash S. Masand · 2013 · Expert Opinion on Drug Safety
  80. Antidepressant drug use and future diabetes risk
    Mika Kivimaki B, George David Batty · 2011 · Diabetologia
  81. A Simulation Model to Estimate 10-Year Risk of Coronary Heart Disease Events in Patients with Schizophrenia Spectrum Disorders Treated with Second-Generation Antipsychotic Drugs
    Josep Darbà, Lisette Kaskens, Pedro Aranda, Celso Arango, Julio Bobes, Rafael Carmena, Javier Rejas · 2013 · Annals of Clinical Psychiatry
  82. Osteoporosis in people with severe mental illness: A forgotten condition
    Richard I. G. Holt · 2010 · Maturitas
  83. Current use of second-generation antipsychotics may increase risk of pneumonia in people with schizophrenia
    Peter Michael Haddad · 2013 · Evidence-Based Mental Health
  84. Pre-morbid fertility in psychosis: Findings from the AESOP first episode study
    Jorge Zimbron, Daniel R. Stahl, Gerard A. Hutchinson, Paola Dazzan, Kevin D Morgan, Gillian A. Doody, Peter Brian Jones, Robin M. Murray, Paul Fearon, Craig Morgan et al. · 2014 · Schizophrenia Research
  85. Will lithium damage my kidneys?
    Thomas J. Raedler · 2012 · Journal of Psychiatry and Neuroscience
  86. Varying effects of psychotropic medications on fracture risk in older people
    2009 · Evidence Based Mental Health